Ignite Creation Date:
2024-05-05 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00279890
Status:
COMPLETED
Last Update Posted:
2011-05-23
First Post:
2006-01-18
Brief Title:
Topical Agent for Treatment of Red Skin
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Study Overview
Official Title:
Proof of Concept TrialSR-01 for the Treatment of Rosacea
Status:
COMPLETED
Status Verified Date:
2011-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
SR-01 may reduce facial redness it is a topically applied product The agent will be applied to local skin areas of subjects with red facial skin to assess affect and then applied to the whole face to assess efficacy and safety
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| MCS 385 | None | None | None |